Soleno Therapeutics (SLNO) Revenue & Revenue Breakdown
Soleno Therapeutics Revenue Highlights
Soleno Therapeutics Revenue by Period
Soleno Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | -100.00% |
2017-12-31 | $-1.55B | -107145.41% |
2016-12-31 | $1.45M | 274.34% |
2015-12-31 | $387.56K | 100.00% |
2014-12-31 | - | -100.00% |
2013-12-31 | $3.00M | 100.00% |
2012-12-31 | - | - |
Soleno Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | - | -100.00% |
2023-12-31 | $3.45M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | -100.00% |
2017-12-31 | $734.95M | 100.00% |
2017-09-30 | - | -100.00% |
2017-06-30 | $1.00K | -99.62% |
2017-03-31 | $265.00K | -6.62% |
2016-12-31 | $283.79K | -13.74% |
2016-09-30 | $329.00K | -15.86% |
2016-06-30 | $391.00K | -12.53% |
2016-03-31 | $447.00K | 85.05% |
2015-12-31 | $241.56K | 162.56% |
2015-09-30 | $92.00K | 187.50% |
2015-06-30 | $32.00K | 45.45% |
2015-03-31 | $22.00K | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | -100.00% |
2013-03-31 | $3.00M | - |
Soleno Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ONTX | Traws Pharma | $226.00B | $56.00K |
VECT | VectivBio | $27.34M | $676.00K |
CAPR | Capricor Therapeutics | $25.18M | $3.97M |
BOLT | Bolt Biotherapeutics | $7.88M | $1.27M |
PULM | Pulmatrix | $7.30M | $1.55M |
LYRA | Lyra Therapeutics | $1.56M | $598.00K |
CBIO | Gyre Therapeutics | $794.00K | - |
XFOR | X4 Pharmaceuticals | - | $563.00K |
SLNO | Soleno Therapeutics | - | - |
BPTH | Bio-Path | - | - |
DAWN | Day One Biopharmaceuticals | - | $8.19M |
MBRX | Moleculin Biotech | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
BNTC | Benitec Biopharma | - | $6.00K |
ALRN | Aileron Therapeutics | - | - |
AKTX | Akari Therapeutics | - | - |
ANNX | Annexon | - | - |
DFFN | CervoMed | - | - |
SLNO Revenue FAQ
What is Soleno Therapeutics’s yearly revenue?
Soleno Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. SLNO's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Soleno Therapeutics’s quarterly revenue?
Soleno Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $3.45M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). SLNO's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Soleno Therapeutics’s revenue growth rate?
Soleno Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.